Paratek Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapies for serious infections. With a commitment to addressing unmet medical needs, Paratek specializes in antibiotics and aims to enhance patient outcomes through its strategic partnerships with national payers, managed care organizations, and other healthcare stakeholders. The company emphasizes collaboration, resourcefulness, and a passionate approach to improving healthcare access and treatment options, while leveraging market insights to drive its strategic planning and operational success.